Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026

STAAR Surgical Company (STAA)

Nasdaq Health Care Health Care Equipment S&P SmallCap 600
$25.21
-1.51 (-5.65%)
Close of Nov 06, 2026 · end-of-day data
Source: STAAR Surgical Company's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 05, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2020FY2021FY2021FY2022FY2023FY2024FY2026
Revenue$23.32M$22.29M$22.87M$20.86M$22.05M$230.47M$239.44M$322.42M$313.90M$239.44M
Cost of revenue$24.06M$26.33M$32.44M$38.23M$45.10M$51.84M$61.01M$69.76M$74.32M$57.02M
Gross profit$58.37M$64.28M$91.51M$111.95M$118.36M$178.64M$223.38M$252.65M$239.58M$182.42M
Research & development$20.67M$20.04M$22.03M$25.30M$31.92M$33.86M$35.98M$40.48M$45.32M$40.05M
Selling, general & admin$71.02M$67.91M$84.92M$100.10M$111.59M$145.30M$179.58M$224.55M$252.19M$274.13M
Operating income-$12.65M-$3.63M$6.59M$11.85M$6.77M$33.34M$43.80M$28.10M-$12.61M-$91.71M
Interest expense$112.00K$112.00K————————
Pre-tax income-$12.44M-$2.30M$6.64M$13.03M$8.27M$31.30M$45.55M$33.70M-$9.05M-$82.26M
Income tax-$315.00K-$157.00K$1.67M-$1.02M$2.35M$3.79M$5.89M$12.35M$11.16M-$1.81M
Net income-$12.13M-$2.14M$4.97M$14.05M$5.91M$27.51M$39.66M$21.35M-$20.21M-$80.45M
EBITDA-$9.99M-$498.00K$9.03M$15.52M$9.83M$36.95M$48.28M$33.21M-$5.72M-$83.39M
EPS (basic)$-0.30$-0.05$0.12$0.32$0.13$0.58$0.83$0.44$-0.41$-1.62
EPS (diluted)$-0.30$-0.05$0.11$0.30$0.12$0.56$0.80$0.43$-0.41$-1.62
Diluted shares40.33M41.00M45.26M46.90M47.95M49.46M49.38M49.43M49.12M49.57M
Gross margin250.3%288.4%400.1%536.6%536.7%77.5%93.3%78.4%76.3%76.2%
Operating margin-54.3%-16.3%28.8%56.8%30.7%14.5%18.3%8.7%-4.0%-38.3%
Net margin-52.0%-9.6%21.7%67.3%26.8%11.9%16.6%6.6%-6.4%-33.6%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2020FY2021FY2021FY2022FY2023FY2024FY2026
Cash & equivalents$14.00M$18.52M$103.88M$119.97M$152.45M$199.71M$86.48M$183.04M$144.16M$153.15M
Short-term investments——————$125.16M$37.69M$86.33M$34.39M
Receivables$16.34M$17.85M$25.95M$31.00M$35.23M$43.53M$62.45M$94.70M$77.90M$50.06M
Total current assets$49.52M$53.89M$151.57M$174.67M$216.42M$271.41M$311.72M$365.27M$367.94M$311.55M
Goodwill$1.79M$1.79M$1.79M$1.79M$1.79M$1.79M$1.79M$1.79M$1.79M$1.79M
Total assets$65.48M$67.93M$167.34M$207.52M$257.42M$345.78M$418.82M$488.69M$509.52M$451.68M
Total current liabilities$21.07M$19.09M$27.73M$34.48M$41.24M$48.80M$51.72M$65.04M$70.31M$68.50M
Total liabilities$27.57M$25.00M$34.91M$47.64M$60.19M$87.22M$82.71M$102.74M$112.19M$107.49M
Shareholders' equity$37.91M$42.94M$132.43M$159.88M$197.22M$261.57M$336.11M$385.95M$397.33M$344.18M

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2020FY2021FY2021FY2022FY2023FY2024FY2026
Operating cash flow$1.05M$2.85M$12.77M$25.80M$20.95M$43.96M$35.72M$14.59M$15.72M-$34.23M
Capital expenditures$3.21M$1.05M$2.25M$10.10M$8.40M$13.64M$18.11M$18.19M$23.39M$5.82M
Free cash flow-$2.16M$1.81M$10.52M$15.70M$12.55M$30.32M$17.61M-$3.59M-$7.67M-$40.05M
Investing cash flow-$3.21M-$1.05M-$2.25M-$10.18M-$8.40M-$13.64M-$156.38M$74.35M-$59.22M$46.34M
Financing cash flow$2.95M$2.44M$74.64M$149.00K$19.57M$17.79M$8.30M$7.42M$5.72M-$4.55M
Share buybacks—————————$6.46M
Stock-based compensation$8.56M$3.16M$6.76M$10.55M$12.15M$14.61M$20.37M$23.52M$27.21M$30.59M
Depreciation & amortization$2.66M$3.13M$2.43M$3.67M$3.06M$3.61M$4.48M$5.11M$6.89M$8.32M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.